Members With High Deductibles Choose Lower-Cost Options


Consumers who choose high deductible health plans (HDHPs), which feature lower premiums and higher deductibles, are more likely than members of other health plans to choose lower cost options, such as generic medications versus brand-name drugs, and to take better care of their health.

Two studies conducted by Independence Blue Cross sought to learn more about consumers’ attitudes toward taking active roles in their health care and whether their behaviors back up their beliefs.

The company found that HDHP members were more engaged in making health care decisions than consumers in traditional managed care plans such as PPOs or HMOs. Fifty-seven percent of HDHP members with chronic conditions say they are actively involved in treatment decisions. Only 37 percent of members who are enrolled in other managed care plans say this.

Health plans are also a key source of information. Consumers traditionally look to their physicians, family, and friends for health advice.

The IBC study found that health plans are perceived as a viable source of information, particularly when exploring treatment options or the cost of care.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.